The present invention is based on the discovery of novel polymorphisms
(SNPs) in the genes known in the art to contribute to human disease. Such
polymorphisms can lead to a variety of disorders that are
mediated/modulated by a variant human disease associated protein. The
present invention provides reagents used for detecting and expressing the
variant nucleic acid/protein sequence as well as methods of identifying
and using these variants.
